In this report, we identified a novel PLPP5‐FGFR1 fusion and TP53 p.H179Y mutation in a 65‐year‐old male patient with lung squamous cell carcinoma (LUSC) through genetic testing of the tumor. This evidence concerns the gene TP53 and squamous cell lung carcinoma.